Risk of cancer is a major concern in the development of drugs for obesity and diabetes. In this fstudy, Brazilian researchers presenting at the annual meeting of the Endocrine Society in March, presented the results of a study that examined whether patients treated with GLP-1RAsad. a higher of breast neoplasms.
Subclinical hypothyroidism is common patients over 70 years old, but how well older patients respond to treatment with levothyroxine (LT4) and liothyronine (LT3) is not well defined.
Study authors hypothesized that longer-acting testosterone replacement therapy will have significant impact on suppressing HPG axis compared with short-acting TRT preparations.
Study authors performed a retrospective review of a thyroid cancer cohort to evaluate the association between metabolic health and severity of thyroid cancer.
Study authors assessed the long-term effectiveness and safety of GH in real-life clinical practice and whether age mattered at the time of treatment initiation.
This study was launched to analyze the effect of setmelanotide, a melanocortin 4 receptor agonist, on weight loss and hunger reduction in patients with obesity and a confirmed diagnosis of Bardet-Biedl syndrome (BBS) or Alströmsyndrome (AS).
Researchers sought to identify whether there were any functional deficits in the developing brains of children with type 1 diabetes due to episodes of hyperglycemia.
